BACKGROUND: In dilated cardiomyopathy (DCM), the clinical and prognostic implications of rare variants in sarcomeric genes remain poorly understood. To address this question, we analyzed the outcome of rare sarcomeric gene variants in patients enrolled in our Familial Cardiomyopathy Registry. METHODS: DCM families harboring rare sarcomeric variants in MYH6, MYH7, MYBPC3, TNNT2, and TTN were identified. Genotype-phenotype association analysis was performed, and long-term survival-free from death or heart transplant was compared between carriers and noncarriers. RESULTS: We found 24 rare variants (3 in MYH6, 3 in MYH7, 3 in MYBPC3, 2 in TNNT2, and 13 in TTN) affecting 52 subjects in 25 families. The phenotypes of variant carriers were severe (3 sudden deaths, 6 heart failure deaths, 8 heart transplants, 2 ventricular fibrillations). There was no difference in the overall long-term survival between carriers and the 33 noncarriers (p = 0.322). However after 50 years of age, the combined endpoint of death or transplant was decreased in carriers as compared to noncarriers (p = 0.026). CONCLUSIONS: Patients with DCM carrying rare variants in sarcomeric genes manifest a poorer prognosis as compared to noncarriers after the age of 50 years. These data further support the role of genetic testing in DCM for risk stratification.
BACKGROUND: In dilated cardiomyopathy (DCM), the clinical and prognostic implications of rare variants in sarcomeric genes remain poorly understood. To address this question, we analyzed the outcome of rare sarcomeric gene variants inpatients enrolled in our Familial Cardiomyopathy Registry. METHODS:DCM families harboring rare sarcomeric variants inMYH6, MYH7, MYBPC3, TNNT2, and TTN were identified. Genotype-phenotype association analysis was performed, and long-term survival-free from death or heart transplant was compared between carriers and noncarriers. RESULTS: We found 24 rare variants (3 in MYH6, 3 in MYH7, 3 in MYBPC3, 2 in TNNT2, and 13 in TTN) affecting 52 subjects in 25 families. The phenotypes of variant carriers were severe (3 sudden deaths, 6 heart failure deaths, 8 heart transplants, 2 ventricular fibrillations). There was no difference in the overall long-term survival between carriers and the 33 noncarriers (p = 0.322). However after 50 years of age, the combined endpoint of death or transplant was decreased in carriers as compared to noncarriers (p = 0.026). CONCLUSIONS:Patients with DCM carrying rare variants in sarcomeric genes manifest a poorer prognosis as compared to noncarriers after the age of 50 years. These data further support the role of genetic testing in DCM for risk stratification.
Authors: Elisa Carniel; Matthew R G Taylor; Gianfranco Sinagra; Andrea Di Lenarda; Lisa Ku; Pamela R Fain; Mark M Boucek; Jean Cavanaugh; Snjezana Miocic; Dobromir Slavov; Sharon L Graw; Jennie Feiger; Xiao Zhong Zhu; Dmi Dao; Debra A Ferguson; Michael R Bristow; Luisa Mestroni Journal: Circulation Date: 2005-07-05 Impact factor: 29.690
Authors: L Mestroni; B Maisch; W J McKenna; K Schwartz; P Charron; C Rocco; F Tesson; A Richter; A Wilke; M Komajda Journal: Eur Heart J Date: 1999-01 Impact factor: 29.983
Authors: Matthew R G Taylor; Dobromir Slavov; Andreas Gajewski; Sylvia Vlcek; Lisa Ku; Pamela R Fain; Elisa Carniel; Andrea Di Lenarda; Gianfranco Sinagra; Mark M Boucek; Jean Cavanaugh; Sharon L Graw; Patsy Ruegg; Jennie Feiger; Xiao Zhu; Debra A Ferguson; Michael R Bristow; Josef Gotzmann; Roland Foisner; Luisa Mestroni Journal: Hum Mutat Date: 2005-12 Impact factor: 4.878
Authors: Edward Blair; Charles Redwood; Marisa de Jesus Oliveira; J C Moolman-Smook; Paul Brink; V A Corfield; Ingegerd Ostman-Smith; Hugh Watkins Journal: Circ Res Date: 2002-02-22 Impact factor: 17.367
Authors: Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev Journal: Nat Methods Date: 2010-04 Impact factor: 28.547
Authors: Ray E Hershberger; Sharie B Parks; Jessica D Kushner; Duanxiang Li; Susan Ludwigsen; Petra Jakobs; Deirdre Nauman; Donna Burgess; Julie Partain; Michael Litt Journal: Clin Transl Sci Date: 2008-05 Impact factor: 4.689
Authors: Elham Kayvanpour; Farbod Sedaghat-Hamedani; Ali Amr; Alan Lai; Jan Haas; Daniel B Holzer; Karen S Frese; Andreas Keller; Katrin Jensen; Hugo A Katus; Benjamin Meder Journal: Clin Res Cardiol Date: 2016-08-30 Impact factor: 5.460
Authors: Marta Gigli; Rene L Begay; Gaetano Morea; Sharon L Graw; Gianfranco Sinagra; Matthew R G Taylor; Henk Granzier; Luisa Mestroni Journal: Front Cardiovasc Med Date: 2016-07-21
Authors: Rene L Begay; Sharon Graw; Gianfranco Sinagra; Marco Merlo; Dobromir Slavov; Katherine Gowan; Kenneth L Jones; Giulia Barbati; Anita Spezzacatene; Francesca Brun; Andrea Di Lenarda; John E Smith; Henk L Granzier; Luisa Mestroni; Matthew Taylor Journal: J Am Heart Assoc Date: 2015-11-13 Impact factor: 5.501